OQROGet OQRO Pro
Insider trade

Genelux (GNLX)Officer sold ~$5.2K

Yong Yu, Officer at Genelux, sold ~$5.2K of Genelux shares.

~$5.2K
Approx. value · 973 sh @ $5.37
146K
Holds after · shares reported
Traded
Nov 17, 2025
Filed
Dec 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 21, 2025Insider · 4 peopleInsiders: 5 sales (~$66K)
  2. Sep 3, 2025InsiderOfficer sold ~$1.9K of GNLX shares in the open market
  3. Nov 17, 2025 · this disclosureInsiderOfficer sold ~$5.2K of GNLX shares in the open market

What came next

  1. Nov 17, 2025Insider · 3 peopleInsiders: 3 sales (~$31K)
  2. Dec 1, 2025InsiderDirector sold ~$50K of GNLX shares in the open market
  3. Dec 5, 2025InsiderOfficer sold ~$774 of GNLX shares in the open market
  4. Dec 30, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 30, 2025, Paul Scigalla, M.D. resigned as Chief Medical Officer of Genelux Corporation (the “ Company ”), effective immediately. Appointment of Jason Litten, M.D. as Chief Medical Officer On January 2, 2026, the Company announced the appointment of Jason Litten, M.D. as the Company’s Chief Medical Officer, effective as of January 2, 2026 (the “ Effective Date ”).”
  5. Mar 2, 2026InsiderDirector sold ~$29K of GNLX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Genelux

For Genelux, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GNLX page.

Other recent filings by Yong Yu, SVP, Clinical Development

The full history of Yong Yu, SVP, Clinical Development is on the profile page.

How this filing works

Other disclosures at Genelux

Everything OQRO holds on this company is on its GNLX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data